MANAT BIO, INC.

Profile

Company Names

MANAT BIO, INC.

Addresses

1300 THAMES STREET, SUITE 20, BALTIMORE, MD 21231

Phone Numbers

(301) 615-0491

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2020

State Incorporated:

DELAWARE

Total Amount Raised:

$72,147,626.00

Number of Funding Rounds:

1
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
1
2023-10-10 
$72,147,626.00 
$152,960,126.00 
$80,812,500.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
RAYMOND 
 
CAMAHORT 
DIRECTOR
INSPIRNA, INC.   |  RAY THERAPEUTICS, INC.   |  MANAT BIO, INC.   |  NEWLEOS THERAPEUTICS, INC.
MANAT 
 
HOLDINGS, LLC 
PROMOTER
MANAT BIO, INC.
JACK 
 
NIELSEN 
DIRECTOR
PROTEIN FOREST, INC.   |  ALIOS BIOPHARMA INC   |  NEOMEND INC   |  APOLLO ENDOSURGERY INC   |  BIOCLIN THERAPEUTICS, INC.   |  UNCHAINED LABS   |  KANYOS BIO, INC.   |  PROCEPT BIOROBOTICS CORP   |  APOLLO ENDOSURGERY US INC   |  HARMONY BIOSCIENCES II, INC.   |  MACULOGIX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  INSTIL BIO, INC.   |  OCELOT BIO, INC.   |  VIVO INNOVATION FUND II, L.P.   |  INSPIRNA, INC.   |  MANAT BIO, INC.
ANDREW 
 
PARDOLL 
DIRECTOR
MANAT BIO, INC.
CARY 
G. 
PFEFFER 
EXECUTIVE OFFICER, DIRECTOR
ELEVEN BIOTHERAPEUTICS, INC.   |  JOUNCE THERAPEUTICS, INC.   |  MANAT BIO, INC.
ANDREA 
 
VAN ELSAS 
EXECUTIVE OFFICER, DIRECTOR
MANAT BIO, INC.
R. 
JACOB 
VOGELSTEIN 
DIRECTOR
CATALIO NEXUS FUND III, LP   |  CATALIO ACCESS FUND V, LLC   |  CATALIO GENESIS FUND II, LLC   |  CATALIO SPECIAL OPPORTUNITIES FUND III, LLC   |  CATALIO CREDIT OPPORTUNITIES FUND I LP   |  CATALIO STRUCTURED OPPORTUNITIES FUND I LP   |  MANAT BIO, INC.   |  CATALIO PUBLIC EQUITIES FUND, LP   |  CATALIO PUBLIC EQUITIES OFFSHORE FUND, LTD.   |  CATALIO ACCESS FUND VII, LLC   |  CATALIO NEXUS FUND IV, LP   |  CATALIO STRUCTURED OPPORTUNITIES OFFSHORE FUND II, LP   |  CATALIO STRUCTURED OPPORTUNITIES FUND II, LP   |  CATALIO NEXUS OFFSHORE FUND IV, LP   |  CATALIO INFLECTION FUND I, LLC   |  CATALIO GENESIS FUND VI, LLC   |  CATALIO GENESIS FUND VIII, LLC   |  CATALIO GENESIS FUND IX, LLC   |  CATALIO GENESIS FUND X, LLC   |  CATALIO ACCESS FUND X, LLC   |  CATALIO ACCESS FUND IX, LLC   |  CATALIO ACCESS FUND VIII, LLC   |  CATALIO INFLECTION FUND II, LLC   |  CATALIO INFLECTION FUND III, LLC   |  CATALIO ACCESS FUND XI, LLC
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2023-10-25
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2023-10-10 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#